LRRK2 p.M1646T is associated with glucocerebrosidase activity and with Parkinson’s disease

Data Availability
Code available at https://github.com/gan-orlab/LRRK2_GCase. Part of the data used in the preparation of this article were obtained from the Parkinson’s Progression Markers Initiative (PPMI) database (www.ppmiinfo.org/data). For up-to-date information on the study, visit www.ppmiinfo.org. PPMI a public private partnership is funded by the Michael J. Fox Foundation for Parkinson’s Research and funding partners, including (list the full names of all of the PPMI funding partners found at www.ppmiinfo.org/fundingpartners). We would like to thank the 23andMe research team. We would like to also thank all members of the International Parkinson Disease Genomics Consortium (IPDGC). For a complete overview of members, acknowledgements and funding, please see http://pdgenetics.org/partners.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
- Addiction Medicine (423)
- Allergy and Immunology (746)
- Anesthesia (219)
- Cardiovascular Medicine (3234)
- Dermatology (270)
- Emergency Medicine (476)
- Epidemiology (13250)
- Forensic Medicine (19)
- Gastroenterology (891)
- Genetic and Genomic Medicine (5066)
- Geriatric Medicine (471)
- Health Economics (773)
- Health Informatics (3189)
- Health Policy (1129)
- Hematology (423)
- HIV/AIDS (1005)
- Medical Education (468)
- Medical Ethics (125)
- Nephrology (513)
- Neurology (4811)
- Nursing (254)
- Nutrition (716)
- Oncology (2483)
- Ophthalmology (703)
- Orthopedics (279)
- Otolaryngology (337)
- Pain Medicine (320)
- Palliative Medicine (89)
- Pathology (531)
- Pediatrics (1281)
- Primary Care Research (550)
- Public and Global Health (7372)
- Radiology and Imaging (1669)
- Respiratory Medicine (970)
- Rheumatology (473)
- Sports Medicine (416)
- Surgery (534)
- Toxicology (69)
- Transplantation (233)
- Urology (199)